相关实验视频
Updated: Sep 16, 2025

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.8K
从大豆蛋白水解物中提取和表征新型,以改善基于分子对接,分子动力学模拟和机制验证的胰岛素耐药性
Yue Xu1, Chun-Min Ma1, Yan Wang1
1Key Laboratory of Food Science and Engineering of Heilongjiang Province, College of Food Engineering, Harbin University of Commerce, Harbin, Heilongjiang 150028, China.
International journal of biological macromolecules
|July 7, 2025
概括
豆蛋白副产品被转化为四种,抑制蛋白氨酸酸酶1B (PTP1B),这是改善胰岛素抵抗的关键目标. K-8-F表现出最强烈的活性,为开发治疗性提供了一种可持续的方法.
科学领域:
- 生物化学 生物化学
- 食品科学 食品科学 食品科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胰岛素抵抗 (IR) 是一种与PTP1B活性相关的代谢障碍.
- 豆蛋白是一种农业工业副产品,是生物活性的潜在来源.
- 开发用于IR的新型治疗剂是一个重大的健康挑战.
研究的目的:
- 从大豆蛋白中识别和描述PTP1B抑制.
- 研究这些的PTP1B抑制机制.
- 评估这些在改善胰岛素抵抗方面的潜力.
主要方法:
- 豆蛋白的酶式生物转化,然后进行活动导向的净化.
- 在片选,分子动力学,并对机理阐明的对接.
- 在体外测试 (Lineweaver-Burk图谱,IC50测定) 和体内验证 (西部涂抹).
主要成果:
- 确定了四种PTP1B抑制性 (D-8-N,K-8-F,K-11-M,D-10-E) 的发现.
- 体显示出非竞争性全抑制PTP1B.
- K-8-F显示了最高的抑制功效 (IC50 = 1.65 ± 0.81 μM),并通过PTP1B/IRS1/AKT途径改善了IR.
结论:
- 豆蛋白副产品可以被提升为针对PTP1B的治疗性.
- K-8-F是一种强大的PTP1B抑制剂,有可能用于IR治疗.
- 这项研究提出了生物活性发现和食品副产品利用的可持续战略.
相关概念视频
Glucagon-like Receptor Agonists
431
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
431
Insulin: Biosynthesis, Chemistry, and Preparation
569
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
569
Protein-protein Interfaces
13.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.4K

